Synlogic (NASDAQ:SYBX) just reported results for the first quarter of 2024. Synlogic reported earnings per share of -$2.60. This was below the analyst estimate for EPS of -82 cents. The company ...

Synlogic (NASDAQ:SYBX) just reported results for the second quarter of 2024. Synlogic reported earnings per share of -15 cents. This was above the analyst estimate for EPS of -51 cents. The company ...

Wall Street expects a year-over-year decline in earnings on lower revenues when Synlogic, Inc. (SYBX) reports results for the quarter ended March 2023. While this widely-known consensus outlook is ...

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide ...

Germany-based Affimed is trading at $0.64 as of July 13, while its analyst price target is $6. This stock price target shows an upside potential of a whopping 837% from the current levels.

CAMBRIDGE, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the ...